Pharma Equity Group A/S
PEG.CO · CPH
6/30/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| - Cash | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| + Debt | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Enterprise Value | DKK 0 | DKK 0 | DKK 0 | DKK 0 |
| Revenue | – | DKK 0 | DKK 0 | DKK 0 |
| % Growth | – | – | – | – |
| Gross Profit | – | DKK 0 | -DKK 0 | -DKK 0 |
| % Margin | – | – | – | – |
| EBITDA | – | -DKK 0 | -DKK 0 | -DKK 0 |
| % Margin | – | – | – | – |
| Net Income | – | -DKK 0 | -DKK 0 | -DKK 0 |
| % Margin | – | – | – | – |
| EPS Diluted | – | -0.006 | -0.006 | -0.006 |
| % Growth | – | -1.7% | -3.5% | – |
| Operating Cash Flow | – | -DKK 0 | -DKK 0 | -DKK 0 |
| Capital Expenditures | – | DKK 0 | DKK 0 | DKK 0 |
| Free Cash Flow | – | -DKK 0 | -DKK 0 | -DKK 0 |